Airdate: Tuesday, November 26, 2019 Season: 6 Episode: 6
Guests: Robert Gould, Michael Girand
Dr. Robert Gould from Wake Forest School of Medicine and Michael Girand from DSI answer questions from a webinar discussing methods and applications for the use of EEG as a biomarker for sleep, substance use disorder and CNS disorders.
For more information or to watch the webinar, click here.
Associated Webinar: Harnessing EEG Methods to Improve Basic and Translational Research for CNS Disorders
Similar Podcasts
Talking Real Science with Oliver Wearing
Oliver Wearing shares what led him to study the relationship between cardiovascular physiology and the autonomic nervous system, how achieving his various positions and awards have allowed him to pursue his research goals, and where he hopes to take his work next.
Talking Real Science with Micaela Merrill
Micaela Merrill discusses her inspiration for science, as well as where she plans to take her career in the future. Her current project is a subset of a larger research story that seeks to understand the risk factors and comorbidities of PTSD in a metropolitan population of Black Americans.
#ExpertAnswers: Fan Wu and Lidor Spivak on Electrophysiological Data Analysis using Artificial Intelligence
Fan Wu and Lidor Spivak discuss automating electrophysiological data analysis using artificial intelligence and introduced a new cloud-based platform applying these methods.
Related Content
Implantable Circuit-Specific Treatments for Autonomic Dysfunction
In this webinar, Dr. Aaron Phillips will present his research on the neural mechanisms of hemodynamic stability.
Calcium Signaling in Neurons and Glia in the Mouse Brain During Exploratory Behavior
In this webinar, Alexey Semyanov, PhD, and Amit Agarwal, PhD, present their work on activity and calcium signaling in neurons, astrocytes, and oligodendrocyte precursor cells (OPCs) during exploratory locomotion behavior in awake and head-fixed mice.
Compensatory Mechanisms in Parkinson’s Disease
Bas Bloem, MD will review compensatory mechanisms, including cerebral plasticity and behavioral adaptation, in persons with Parkinson's disease.